Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population

Prognostic impact of CD4-positive T cell subsets in early breast cancer: a study based on the FinHer trial patient population

Abstract Background The clinical importance of tumor-infiltrating cluster of differentiation 4 (CD4) T cells is incompletely understood in early breast cancer. We investigated the clinical significance of CD4, forkhead box P3 (FOXP3), and B cell attracting chemokine leukocyte chemoattractant-ligand...

Full description

Bibliographic Details
Main Authors: Marcus Schmidt, Veronika Weyer-Elberich, Jan G. Hengstler, Anne-Sophie Heimes, Katrin Almstedt, Aslihan Gerhold-Ay, Antje Lebrecht, Marco J. Battista, Annette Hasenburg, Ugur Sahin, Konstantine T. Kalogeras, Pirkko-Liisa Kellokumpu-Lehtinen, George Fountzilas, Ralph M. Wirtz, Heikki Joensuu
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Breast Cancer Research
Subjects:
Breast cancer
Prognosis
Immune system
Humoral
Tumor-infiltrating lymphocytes
Online Access:http://link.springer.com/article/10.1186/s13058-018-0942-x

Internet

http://link.springer.com/article/10.1186/s13058-018-0942-x

Similar Items